
Glimaday P 1mg/500mg/15mg Tablet ER
Marketer
Wockhardt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimaday P 1mg/500mg/15mg Tablet ER
Combiflex-DP 1mg/500mg/15mg Extended-Release tablets are a triple-combination medication designed to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, leading to reduced blood sugar. Always adhere to your doctor's prescribed dosage and regimen for Combiflex-DP 1mg/500mg/15mg ER tablets. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your normal schedule. Never double the dose. Overdosing can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or lactating individuals should consult their doctor before use. Kidney function tests will be conducted before commencing therapy. Limit alcohol consumption as it may heighten the risk of certain side effects.
Uses of Glimaday P 1mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glimaday P 1mg/500mg/15mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without crushing, chewing, or fracturing it. Consume Glimaday P 1mg/500mg/15mg Extended-Release Tablet with food.
Common Side effects of Glimaday P 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimaday P 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimaday P 1mg/500mg/15mg Extended-Release Tablet with a meal.
How Glimaday P 1mg/500mg/15mg Tablet ER works:
Glimaday P 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ separate actions to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimaday P 1mg/500mg/15mg Tablet ER with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glimaday P tablets (1mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimaday P tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimaday P 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Regular monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimaday P 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical consultation is advised. Glimaday P 1mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimaday P 1mg/500mg/15mg Tablet ER :
Should you forget a Glimaday P 1mg/500mg/15mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimaday P 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
